Summary by Moomoo AI
Sai Seng Pharmaceutical Holdings Limited announced on 8 April 2024 that its privatization transaction has been completed. Pursuant to Rule 22 of the Hong Kong Code of Companies Acquisitions and Mergers, CICC Wealth Investment Limited completed on 2 April 2024 the liquidation of derivatives contracts related to the pharmaceutical industry. The transaction consists of two contracts involving 167,500 shares each; the first contract has a reference price of $17.7753 per share for a total amount of $2,977,370.62; the second contract has a reference price of $17.7715 per share for a total amount of $2,976,729.60. Following the transaction, CICC Wealth Investment Limited held by CICC Wealth Investment Limited was zero. CICC Wealth Investment Limited is a subsidiary of China International Financial Corporation and is associated with the underwriters of Sai Sai Sang Pharmaceuticals. This disclosure replaces the previous disclosure form dated April 3, 2024.